QUIANA JACKSON: Open Payments
NPI 1447435300 · OLYMPIA FIELDS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 35 payments from 10 companies in 2025. Trend: 2023 $670 · 2024 $682 · 2025 $604
Food & beverage: $604
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $190 |
| Lilly USA, LLC | 9 | $111 |
| ABBVIE INC. | 5 | $94 |
| ViiV Healthcare Company | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Ardelyx, Inc. | 1 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: Rybelsus, MOUNJARO, APRETUDE, VRAYLAR, REXULTI, Ozempic, ZEPBOUND, Wegovy.
Industry payments across IL — which companies pay providers there.
